Cinqair- A USFDA approved anti-asthmatic drug | Pharmaffiliates

Cinqair- A USFDA approved anti-asthmatic drug

Published Aug 21, 2019 by pharmaffiliates
Cinqair-A USFDA approved anti-asthmatic drug

FDA, which is an agency within the U.S. Department of Health and Human Services, is responsible to protect the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices.

FDA is also responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

Recently, FDA has announced great news for the patients suffering from severe asthma.

Asthma, which is a chronic disease that causes inflammation in the airways of the lungs.According to the Centers for Disease Control and Prevention more than 22 million people in the U.S. have asthma, and there are more than 400,000 asthma-related hospitalizations each year.

During an asthma attack, airways become narrow making it hard to breathe. Severe asthma attacks can lead to asthma-related hospitalizations because these attacks can be serious and even life-threatening.

U.S FDA approved drug used to treat severe asthma is Cinqair which is made by Teva Pharmaceuticals in Frazer, Pennsylvania.

Cinqair (reslizumab) is a humanized interleukin-5 (IL-5) antagonist monoclonal antibody produced by recombinant DNA technology in murine myeloma non-secreting 0 (NS0) cells. Cinqair reduces severe asthma attacks by reducing the levels of blood eosinophils, a type of white blood cell that contributes to the development of asthma.

Pharmaffiliates Analytics and Synthetics P. Ltd. offersTrastuzumab and Pertuzumab as monoclonal antibodies similar to Reslizumab.

Details are mentined below

Trastuzumab :

Pertuzumab :

These monoclonal antibodies are similar to Reslizumab and are readily available at Pharmaffiliates at a very competitive price. We customize the pack size as per the requirement of the customer.

Pharmaffiliates is a gigantic name worldwide which offers its services as a Contract Research Organization to Pharmaceutical organizations, Research institutes, biotechnologies and other allied industries.

Pharmaffiliates is a U.S.FDA approved and accepted organization which also hold esteemed accreditations like ISO 17034:2016, ISO 17025:2005, ISO 9001:2015 and DSIR.

Leave a Reply